C4 Therapeutics Inc (CCCC)
6.09
+0.09
(+1.50%)
USD |
NASDAQ |
May 15, 13:56
C4 Therapeutics Profit Margin (Quarterly): -933.2% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -933.2% |
| December 31, 2023 | -1.07K% |
| September 30, 2023 | -244.2% |
| June 30, 2023 | -1.35K% |
| March 31, 2023 | -925.2% |
| December 31, 2022 | -1.30K% |
| September 30, 2022 | -473.2% |
| June 30, 2022 | -198.1% |
| March 31, 2022 | -413.1% |
| December 31, 2021 | -77.99% |
| Date | Value |
|---|---|
| September 30, 2021 | -290.4% |
| June 30, 2021 | -230.9% |
| March 31, 2021 | -282.4% |
| December 31, 2020 | -263.8% |
| September 30, 2020 | -258.5% |
| June 30, 2020 | -111.6% |
| March 31, 2020 | -174.8% |
| December 31, 2019 | -122.1% |
| September 30, 2019 | -188.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.35K%
Minimum
Jun 2023
-77.99%
Maximum
Dec 2021
-468.7%
Average
-263.8%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| Exact Sciences Corp | -17.29% |
| Alector Inc | -227.0% |
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -19.35K% |
| IGC Pharma Inc | -2.74K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.81% |
| Return on Assets | -33.55% |
| Return on Invested Capital | -50.92% |
| Operating Margin (Quarterly) | -980.0% |
| Return on Net Operating Assets | -161.1% |